The impact of bariatric surgery on insulin-treated type 2 diabetes patients

被引:14
作者
Lemus, Rodrigo [1 ]
Karni, Dror [1 ]
Hong, Dennis [1 ]
Gmora, Scott [1 ]
Breau, Ruth [1 ]
Anvari, Mehran [1 ]
机构
[1] McMaster Univ, G805,50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2018年 / 32卷 / 02期
关键词
Diabetes mellitus; Sleeve gastrectomy; Gastric bypass; Insulin dependence; Remission; Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; METABOLIC SURGERY; OBESE-PATIENTS; WEIGHT-LOSS; REMISSION; MELLITUS; EXPERIENCE; OUTCOMES;
D O I
10.1007/s00464-017-5777-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Bariatric surgery has been shown to lead to significant improvement in glucose homeostasis, resulting in greater rates of type 2 diabetes mellitus (T2DM) remission. While there is substantial evidence of the benefits of bariatric/metabolic surgery in obese diabetic patients on oral therapy (O-T2D), more evidence is necessary in the case of insulin-treated type 2 diabetes (I-T2D) patients and the selection of surgical procedure. Methods Analysis of the Ontario Bariatric Registry data was performed, comparing outcomes of Roux-en-Y-gastric bypass (RYGB) and sleeve gastrectomy (SG) on insulin-treated versus non-insulin-treated T2DM patients. We compared weight loss, medication use and remission rates during a 3-year follow up. Results A total of 3668 diabetic Bariatric Registry patients underwent surgery from Jan 2010 to Feb 2017, across 7 Bariatric Centers of Excellence in Ontario. Of these 2872 were O-T2D and 1187 were I-T2D. Weight loss was similar between the two groups at 3 years; with mean %WL of 30.1% for the insulin group vs. 28.3% non-insulin (p = 0.0673). At 3 years, 11.3% of the non-insulin and 59.6% of the insulin-dependent group were using anti-diabetic medication (p < 0.0001). Among insulin-dependent patients, RYGB showed greater reduction in insulin use with 26.5 and 40% compared to SG at 3 years. O-T2D patients experienced more complete diabetes remission, with 66.5 vs. 18.5% (p < 0.0001) at 3 years. Complete remission for I-T2D patients was higher in the RYGB group than SG (p < 0.0001) at years 1 and 2 (8.5 vs. 5.4% and 24.4 vs. 21.1%). The same trend was found regardless of insulin use; complete remission higher for RYGB at 1 and 2 years [50.7 vs. 39.8% (p < 0.0001), and 54.6 vs. 49.1% (p < 0.0001)]. Conclusion While both RYGB and SG procedures provide effective treatment for I-T2D patients in terms of weight loss and diabetes, incidence of complete remission for insulin-dependent patients is higher with RYGB in earlier years.
引用
收藏
页码:990 / 1001
页数:12
相关论文
共 32 条
[1]   Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes [J].
Abbatini, F. ;
Rizzello, M. ;
Casella, G. ;
Alessandri, G. ;
Capoccia, D. ;
Leonetti, F. ;
Basso, N. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (05) :1005-1010
[2]   Bariatric Surgery Worldwide 2013 [J].
Angrisani, L. ;
Santonicola, A. ;
Iovino, P. ;
Formisano, G. ;
Buchwald, H. ;
Scopinaro, N. .
OBESITY SURGERY, 2015, 25 (10) :1822-1832
[3]   Insulin Cessation and Diabetes Remission After Bariatric Surgery in Adults With Insulin-Treated Type 2 Diabetes [J].
Ardestani, Ali ;
Rhoads, David ;
Tavakkoli, Ali .
DIABETES CARE, 2015, 38 (04) :659-664
[4]   Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus [J].
Brethauer, Stacy A. ;
Aminian, Ali ;
Romero-Talamas, Hector ;
Batayyah, Esam ;
Mackey, Jennifer ;
Kennedy, Laurence ;
Kashyap, Sangeeta R. ;
Kirwan, John P. ;
Rogula, Tomasz ;
Kroh, Matthew ;
Chand, Bipan ;
Schauer, Philip R. .
ANNALS OF SURGERY, 2013, 258 (04) :628-637
[5]   What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients [J].
Bruno, Graziella ;
Gruden, Gabriella ;
Barutta, Federica ;
Perin, Paolo Cavallo ;
Morino, Mario ;
Toppino, Mauro .
SURGERY FOR OBESITY AND RELATED DISEASES, 2015, 11 (05) :1014-1019
[6]   How Do We Define Cure of Diabetes? [J].
Buse, John B. ;
Caprio, Sonia ;
Cefalu, William T. ;
Ceriello, Antonio ;
Del Prato, Stefano ;
Inzucchi, Silvio E. ;
McLaughlin, Sue ;
Phillips, Gordon L., II ;
Robertson, R. Paul ;
Rubino, Francesco ;
Kahn, Richard ;
Kirkman, M. Sue .
DIABETES CARE, 2009, 32 (11) :2133-2135
[7]   Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity [J].
Cottam, D. ;
Qureshi, F. G. ;
Mattar, S. G. ;
Sharma, S. ;
Holover, S. ;
Bonanomi, G. ;
Ramanathan, R. ;
Schauer, P. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (06) :859-863
[8]   Remission of type 2 diabetes mellitus after bariatric surgery - comparison between procedures [J].
Fernandez-Soto, Maria L. ;
Martin-Leyva, Ana ;
Gonzalez-Jimenez, Amalia ;
Garcia-Rubio, Jesus ;
Cozar-Ibanez, Antonio ;
Zamora-Camacho, Francisco J. ;
Leyva-Martinez, Maria S. ;
Jimenez-Rios, Jose A. ;
Escobar-Jimenez, Fernando .
ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) :18-25
[9]  
Honarmand K, 2017, CLIN OBES, V7, P176, DOI 10.1111/cob.12189
[10]   Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution? [J].
Hutch, Chelsea R. ;
Sandoval, Darleen A. .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1391 (01) :5-19